Na Zhao

8PUBLICATIONS
32CO-AUTHORS
Molecular targetsMicroelectromechanical systems (MEMS)Cancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 17, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.

|Feb 27, 2026
CELF1 is a non-canonical eIF4E binding protein that promotes translation of epithelial-mesenchymal transition effector mRNAs.

Arindam Chaudhury, Natee Kongchan, Shebna A Massey

|Jan 03, 2026
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.

Diego A Pedroza, Xueying Yuan, Fengshuo Liu

|Jun 26, 2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers.

Diego A Pedroza, Xueying Yuan, Fengshuo Liu

|Dec 23, 2024
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses.

Jonathan T Lei, Lacey E Dobrolecki, Chen Huang

|Oct 17, 2024
RPS19 and RPL5, the most commonly mutated genes in Diamond Blackfan anemia, impact DNA double-strand break repair.

Nicholas F DeCleene, Elif Asik, Anthony Sanchez

Pageof 2

Frequent Collaborators

5 joint publications

Jeffrey M Rosen

4 joint publications

Diego A Pedroza

3 joint publications

Xiang H-F Zhang

3 joint publications

Fengshuo Liu